Evidence map›Paper›PMID 31302575›Full record

ArticleInternational journal of pediatric otorhinolaryngology2019

Antibiotic modulation of mucins in otitis media; should this change our approach to watchful waiting?

Wenzhou Hong, Pawjai Khampang, Abigail R Kerschner, Alexander C Mackinnon, Ke Yan, Pippa M Simpson, Joseph E Kerschner

Open access · greenAbstract read
In one paragraph

Article in International journal of pediatric otorhinolaryngology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Association ofFrontiers in oncology · 2021
    Article
  4. Article
  5. A Bacterial Epigenetic Switch in Non-typeableFrontiers in cellular and infection microbiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Wenzhou HongDepartment of Otolaryngology and Communication Sciences, Medical College of Wisconsin, USA.
Pawjai KhampangDepartment of Otolaryngology and Communication Sciences, Medical College of Wisconsin, USA.
Abigail R KerschnerDepartment of Otolaryngology and Communication Sciences, Medical College of Wisconsin, USA.
Alexander C MackinnonDepartment of Pathology, Medical College of Wisconsin, USA.
Ke YanQuantitative Health Sciences, Department of Pediatrics, Medical College of Wisconsin, USA.
Pippa M SimpsonQuantitative Health Sciences, Department of Pediatrics, Medical College of Wisconsin, USA.
Joseph E KerschnerDivision of Pediatric Otolaryngology, Medical College of Wisconsin, USA; Department of Otolaryngology and Communication Sciences, Medical College of Wisconsin, USA. Electronic address: jkerschner@mcw.edu.
Medical College of Wisconsin · US

Funding

CYTOKINE INFLAMMATORY MEDIATORS AND MUCIN REGULATION IN MIDDLE EAR EPITHELIUMR01DC007903 · NIDCD · MEDICAL COLLEGE OF WISCONSIN · PI KERSCHNER, JOSEPH E · 2006 to 2016
$3.4M
NIDCD NIH HHS R01 DC007903
6 · The paper itself

Abstract

backgroundGel-forming mucins (GFMs) play important roles in otitis media (OM) pathogenesis. Increased mucin expression is activated by pathogens and proinflammatory cytokines. Bacterial biofilms influence inflammation and resolution of OM and may contribute to prolonged mucin production. The influence of specific pathogens on mucin expression and development of chronic OM with effusion (OME) remains an area of significant knowledge deficit.

objectivesTo assess the relationship between GFM expression, specific pathogens, middle ear mucosal (MEM) changes, biofilm formation, and antibiotic utilization.

methodsMixed gender chinchillas were inoculated with nontypeable Haemophilus influenzae (NTHi) strain 86028NP or Streptococcus pneumoniae (SP) strain TIGR4 via transbulla injection. Antibiotic was administered on day 3-5 post inoculation. GFM expression was measured by quantitative PCR. Biofilm formation was identified and middle ear histologic changes were measured.

resultsSP infection resulted in higher incidence of biofilm and ME effusion compared with NTHi infection. However, NTHi persisted in the ME longer than SP with no substantive bacterial clearance detected on day 10 compared with complete bacterial clearance on day 10 for 50-60% of the SP-infected chinchillas. Both infections increased MEM inflammatory cell infiltration and thickening. NTHi upregulated the Muc5AC, Muc5B and Muc19 expression on day 10 (p = 0.0004, 0.003, and 0.002 respectively). SP-induced GFM upregulations were trended toward significant. In both NTHi and SP infections, the degree of GFM upregulation had a direct relationship to increased MEM hypertrophy, inflammatory cell infiltration and biofilm formation. Antibiotic treatment reduced the incidence of ME effusion and biofilm, limited the MEM changes and reversed the GFM upregulation. In NTHi infection, the rate of returning to baseline level of GFMs in treated chinchillas was quicker than those without treatment.

conclusionsIn an animal model of OM, GFM genes are upregulated in conjunction with MEM hypertrophy and biofilm formation. This upregulation is less robust and more quickly ameliorated to a significant degree in the NTHi infection with appropriate antibiotic therapy. These findings contribute to the understanding of pathogen specific influences on mucin expression during OM pathogenesis and provide new data which may have implications in clinical approach for OM treatment.

Indexed as

AnimalsAnti-Bacterial AgentsBiofilmsChinchillaDisease Models, AnimalHaemophilus InfectionsHaemophilus influenzaeMucin 5ACMucin-5BOtitis MediaPneumococcal InfectionsStreptococcus pneumoniaeUp-RegulationWatchful WaitingAnti-Bacterial AgentsMucin 5ACMucin-5BAntibiotic treatmentGel-forming mucinsOtitis media

Identifiers

PMID31302575
PMCPMC6742428
OpenAlexW2954242126

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.